Latest News about REGN
Recent news which mentions REGN
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
From InvestorPlace
The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 Experts
February 27, 2024
Tickers
REGN
From Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
February 26, 2024
From Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
February 22, 2024
Tickers
REGN
From Benzinga
2 No-Brainer Biotech Stocks to Buy Right Now
February 21, 2024
From Motley Fool
From Benzinga
2 Top Growth Stocks to Buy With $1,000 Right Now
February 18, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
From Benzinga
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
From Motley Fool
From InvestorPlace
4D Molecular Therapeutics' 4D-150 Phase 2 Data Met Investor Expectations, Analyst Boosts Forecast
February 06, 2024
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $6,400 Today
February 06, 2024
From Benzinga
Cantor Fitzgerald Maintains Neutral Rating for Regeneron Pharmaceuticals: Here's What You Need To Know
February 06, 2024
Tickers
REGN
From Benzinga
Stock-Split Watch: Could These 2 Market-Beaters Be Next?
February 06, 2024
From Motley Fool
From Benzinga
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
From Benzinga
Nasdaq Futures Climb As Meta, Amazon Gains Offset Apple Slide: Analyst Points to 2 Factors Reinforcing Bullish Outlook This Year
February 02, 2024
From Benzinga
Earnings Scheduled For February 2, 2024
February 02, 2024
From Benzinga
3 Top Pharma Stocks to Buy Now: February 2024
February 01, 2024
From InvestorPlace
AI, Biotech, Energy Sectors Expect M&A Revival For 2024
January 29, 2024
From Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
From Benzinga
3 Magnificent Stocks to Buy and Hold Forever
January 27, 2024
From Motley Fool
Regeneron/Sanofi's Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation
January 26, 2024
From Benzinga
Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts
January 24, 2024
From Benzinga
3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024
January 23, 2024
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
